Duato Joaquin

CEO and Chairman of the Board at JNJ

Sold, on record
$101M
Dollars the filings state
Form 4 sales
6
Latest Aug 13, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • JNJJOHNSON & JOHNSONCEO and Chairman of the Board

Sales by reason

0
Routine
0
Plan not stated
1
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale JNJUnusual
    Mar 3, 2017 2017

    Sold 50,000 shares at $123.62 ($6.2M)

    Duato Joaquin, Exec VP, WW Chair, Pharma

    Sold 42.2% of holdings ($14.7M position)68,536 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale JNJUnusual
    Nov 7, 2018 +614 days

    Sold 40,000 shares at $144.36 ($5.8M)

    Duato Joaquin, Vice Chair, Exec Committee

    Sold 30% of holdings ($19.3M position)93,555 shares leftFiling

  3. 3 Form 144 notice JNJNotice
    Aug 22, 2025 +2480 days

    Filed to sell 125,824 shares ($22.7M)

    Duato Joaquin, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale JNJUnusual
    Aug 22, 2025 same day

    Sold 125,824 shares at $179.21 ($22.5M)

    Duato Joaquin, CEO and Chairman of the Board

    No 10b5-1 planSold 31.3% of holdings ($72M position)275,967 shares leftFirst sale on recordFollows a Form 144Filing

  5. 5 Form 144 notice JNJNotice
    Jan 26, 2026 +157 days

    Filed to sell 100,000 shares ($22M)

    Duato Joaquin, CEO, Chariman

    No 10b5-1 planFiling

  6. 6 Form 4 sale JNJUnusual
    Jan 26, 2026 same day

    Sold 100,000 shares at $221.23 ($22.1M)

    Duato Joaquin, CEO and Chairman of the Board

    No 10b5-1 planSold 76.4% of holdings ($28.9M position)30,852 shares leftFollows a Form 144Filing

  7. 7 Form 4 sale JNJNo plan
    Aug 5, 2026 +191 days

    Sold 48,480 shares at $258.15 ($12.5M)

    Duato Joaquin, CEO and Chairman of the Board

    No 10b5-1 planSold 14.9% of holdings ($83.8M position)275,967 shares leftFiling

  8. 8 Form 4 sale JNJUnusual
    Aug 13, 2026 +8 days

    Sold 123,291 shares at $261.17 ($32.2M)

    Duato Joaquin, CEO and Chairman of the Board

    No 10b5-1 planSold 30.9% of holdings ($104M position)275,967 shares left1.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Duato Joaquin
Source
Aug 13, 2026Aug 14, 2026JNJCEO and Chairman of the BoardForm 4 sale123,291$32.2M30.9%UnusualSEC
Aug 5, 2026Aug 7, 2026JNJCEO and Chairman of the BoardForm 4 sale48,480$12.5M14.9%No planSEC
Jan 26, 2026Jan 28, 2026JNJCEO and Chairman of the BoardForm 4 sale100,000$22.1M76.4%UnusualSEC
Jan 26, 2026Jan 26, 2026JNJCEO, CharimanForm 144 notice100,000$22MNoticeSEC
Aug 22, 2025Aug 25, 2025JNJCEO and Chairman of the BoardForm 4 sale125,824$22.5M31.3%UnusualSEC
Aug 22, 2025Aug 22, 2025JNJOfficer, DirectorForm 144 notice125,824$22.7MNoticeSEC
Nov 7, 2018Nov 9, 2018JNJVice Chair, Exec CommitteeForm 4 sale40,000$5.8M30.0%UnusualSEC
Mar 3, 2017Mar 7, 2017JNJExec VP, WW Chair, PharmaForm 4 sale50,000$6.2M42.2%UnusualSEC